» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 128 | NO. 123 | Tuesday, June 25, 2013

Supreme Court Says No to Generic Drug Design Lawsuits

AP

Print | Front Page | Email this story | Comments ()

WASHINGTON (AP) – The Supreme Court says generic drug manufacturers can't be sued in state court for a drug's design defects if federal officials approved the brand-name version the generic drug copied.

The justices voted 5-4 to agree with generic manufacturer Mutual Pharmaceutical Co, Inc., which wanted a $21 million judgment against it dismissed.

A New Hampshire jury gave that to Karen L. Bartlett after she took sulindac, the generic form of the drug Clinoril, in 2004. It caused her outer skin layer to deteriorate and burn off, leaving at least 60 percent of her body as an open wound. She is also now legally blind.

The federal appeals courts upheld her verdict, but the justices said federal law pre-empts the New Hampshire law that allowed Bartlett's lawsuit.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 89 304 8,299
MORTGAGES 91 332 9,744
FORECLOSURE NOTICES 0 0 0
BUILDING PERMITS 172 652 17,786
BANKRUPTCIES 32 195 5,955
BUSINESS LICENSES 31 108 3,103
UTILITY CONNECTIONS 38 191 6,447
MARRIAGE LICENSES 29 118 2,075

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.